Affordable Access

[Disseminated carcinoma of the prostate: monotherapy or complete androgenic blockade?].

Authors
Type
Published Article
Journal
Archivos españoles de urología
Publication Date
Volume
50
Issue
10
Pages
1067–1076
Identifiers
PMID: 9494195
Source
Medline
License
Unknown

Abstract

Hormone suppression achieves a response rate of more than 75% and is therefore a valid alternative in the management of metastatic cancer of the prostate. Monotherapy and total androgen blockade have similar survival rates and disease free intervals. However, the results according to prognostic groups are significantly better for those treated with total androgen blockade and has less severe disease, suggesting early treatment.

Statistics

Seen <100 times